Is predicting metastatic pheochromocytoma and paraganglioma still effective without using methoxytyramine?

Emre Sedar Saygili, Yasir Elhassan, Cristina Ronchi^*

^*Corresponding author for this work

Metabolism and Systems Science

Research output: Contribution to journal › Comment/debate › peer-review

34 Downloads (Pure)

Original language	English
Pages (from-to)	e154-e154
Number of pages	1
Journal	The Lancet Digital Health
Volume	6
Issue number	3
Early online date	21 Feb 2024
DOIs	https://doi.org/10.1016/S2589-7500(24)00019-0
Publication status	Published - Mar 2024

Access to Document

10.1016/S2589-7500(24)00019-0Licence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

SaygiliE2024predictingFinal published version, 45.1 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Cite this

@article{a8ac19ca48c24e498af1e0d719f7e800,

title = "Is predicting metastatic pheochromocytoma and paraganglioma still effective without using methoxytyramine?",

author = "Saygili, \{Emre Sedar\} and Yasir Elhassan and Cristina Ronchi",

year = "2024",

month = mar,

doi = "10.1016/S2589-7500(24)00019-0",

language = "English",

volume = "6",

pages = "e154--e154",

journal = "The Lancet Digital Health",

issn = "2589-7500",

publisher = "The Lancet",

number = "3",

}

TY - JOUR

T1 - Is predicting metastatic pheochromocytoma and paraganglioma still effective without using methoxytyramine?

AU - Saygili, Emre Sedar

AU - Elhassan, Yasir

AU - Ronchi, Cristina

PY - 2024/3

Y1 - 2024/3

U2 - 10.1016/S2589-7500(24)00019-0

DO - 10.1016/S2589-7500(24)00019-0

M3 - Comment/debate

SN - 2589-7500

VL - 6

SP - e154-e154

JO - The Lancet Digital Health

JF - The Lancet Digital Health

IS - 3

ER -